Applied Therapeutics, Inc. Additional Paid in Capital
Applied Therapeutics, Inc. had Additional Paid in Capital of $635.76 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2025-11-13
- 2025-09-30: Additional Paid in Capital $635.76M.
- 2025-06-30: Additional Paid in Capital $634.77M.
- 2025-03-31: Additional Paid in Capital $632.67M.
- 2024-12-31: Additional Paid in Capital $631.18M.
| Period end | Additional Paid in Capital |
|---|---|
| 2025-09-30 | $635.76M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $634.77M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $632.67M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $631.18M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $624.10M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $622.01M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $619.81M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $451.43M 10-K · filed 2025-04-15 |
| 2023-09-30 | $419.86M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $384.20M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $354.88M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $352.83M 10-K · filed 2024-03-06 |
| 2022-09-30 | $344.00M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $341.09M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $331.48M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $328.96M 10-K · filed 2023-03-23 |
| 2021-09-30 | $326.11M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $323.36M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $320.28M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $242.78M 10-K · filed 2022-03-10 |
| 2020-09-30 | $240.07M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $237.43M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $234.88M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $99.38M 10-K · filed 2021-03-18 |
| 2019-09-30 | $79.87M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $78.43M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.07M 10-Q · filed 2019-06-21 |
| 2018-12-31 | $1.67M 10-K · filed 2020-03-13 |